WO2005083066A3 - Anhydrofructose-reductase, ihre kodierende nukleotidsequenz und deren verwendung - Google Patents

Anhydrofructose-reductase, ihre kodierende nukleotidsequenz und deren verwendung Download PDF

Info

Publication number
WO2005083066A3
WO2005083066A3 PCT/EP2005/002102 EP2005002102W WO2005083066A3 WO 2005083066 A3 WO2005083066 A3 WO 2005083066A3 EP 2005002102 W EP2005002102 W EP 2005002102W WO 2005083066 A3 WO2005083066 A3 WO 2005083066A3
Authority
WO
WIPO (PCT)
Prior art keywords
anhydrofructose
reductase
nucleotide sequence
coding nucleotide
anhydromannitol
Prior art date
Application number
PCT/EP2005/002102
Other languages
English (en)
French (fr)
Other versions
WO2005083066A2 (de
Inventor
Friedrich Giffhorn
Annette Kuehn
Original Assignee
Univ Saarland
Friedrich Giffhorn
Annette Kuehn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saarland, Friedrich Giffhorn, Annette Kuehn filed Critical Univ Saarland
Publication of WO2005083066A2 publication Critical patent/WO2005083066A2/de
Publication of WO2005083066A3 publication Critical patent/WO2005083066A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Offenbart wird eine Anhydrofructose-Reduktase, welche die Reduktion von Anhydrofructose zu Anhydromannitol zu katalysieren vermag, die die Anhydrofructose­Reduktase kodierende N ukleinsäure, den die Anhydrofructose-Reduktase erkennenden Antikörper, sowie ihre Verwendung in der Diagnostik von krankhaften Blutzuckerstörungen.
PCT/EP2005/002102 2004-02-27 2005-02-28 Anhydrofructose-reductase, ihre kodierende nukleotidsequenz und deren verwendung WO2005083066A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004010131A DE102004010131A1 (de) 2004-02-27 2004-02-27 Anhydrofructose-Reductase, ihre kodierende Nukleotidsequenz und deren Verwendung
DE102004010131.0 2004-02-27

Publications (2)

Publication Number Publication Date
WO2005083066A2 WO2005083066A2 (de) 2005-09-09
WO2005083066A3 true WO2005083066A3 (de) 2005-11-24

Family

ID=34853892

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/002102 WO2005083066A2 (de) 2004-02-27 2005-02-28 Anhydrofructose-reductase, ihre kodierende nukleotidsequenz und deren verwendung

Country Status (2)

Country Link
DE (1) DE102004010131A1 (de)
WO (1) WO2005083066A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2039765B1 (de) * 2006-06-22 2011-10-05 Ikeda Food Research Co. Ltd. Verfahren zur bestimmung von 1,5-anhydroglucitol und reagentienzusammensetzung zur bestimmung von 1,5-anhydroglucitol
CN113512572A (zh) * 2021-04-15 2021-10-19 苏州朗邦营养科技有限公司 一种发酵法高效制备β-葡聚糖的方法、剑菌及其筛选方法

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANDERSEN S M ET AL: "1,5-Anhydro-d-fructose; a versatile chiral building block: biochemistry and chemistry", CARBOHYDRATE RESEARCH, ELSEVIER SCIENTIFIC PUBLISHING COMPANY. AMSTERDAM, NL, vol. 337, no. 10, 13 May 2002 (2002-05-13), pages 873 - 890, XP004352798, ISSN: 0008-6215 *
BUSE JOHN B ET AL: "Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker.", DIABETES TECHNOLOGY & THERAPEUTICS. 2003, vol. 5, no. 3, 2003, pages 355 - 363, XP002344390, ISSN: 1520-9156 *
DAMBE, T. R.: "(Dissertation): Strukturelle Untersuchungen an 1,5-Anhydro-D-fructose-Reduktase aus Sinorhizobium morelense S-30.7.5. und SoxXA aus Paracoccus pantotrophus", 17 March 2005, XP002344391 *
DATABASE EMBL [online] 1 August 2001 (2001-08-01), "Sinorhizobium meliloti 1021 complete chromosome; segment 12/12 Sinorhizobium meliloti 1021 complete chromosome; segment 12/12", XP002344396, retrieved from EBI accession no. EM_PRO:AL591793 Database accession no. AL591793 *
DATABASE EMBL [online] 28 December 2001 (2001-12-28), "Brucella melitensis 16M chromosome I, section 3 of 195 of the complete sequence.", XP002344397, retrieved from EBI accession no. EM_PRO:AE009446_3 Database accession no. AE009446 *
SAKUMA MOTOKI ET AL: "Purification and some properties of a hepatic NADPH-dependent reductase that specifically acts on 1,5-anhydro-D-fructose", JOURNAL OF BIOCHEMISTRY (TOKYO), vol. 123, no. 1, January 1998 (1998-01-01), pages 189 - 193, XP002344389, ISSN: 0021-924X *

Also Published As

Publication number Publication date
DE102004010131A1 (de) 2005-09-15
WO2005083066A2 (de) 2005-09-09

Similar Documents

Publication Publication Date Title
WO2005111212A3 (en) Biological bar code
WO2005014850A3 (en) Systems and methods for analyzing nucleic acid sequences
WO2004074455A3 (en) Fc REGION VARIANTS
WO2006101851A3 (en) Microfluidic system
WO2007133290A8 (en) Anti-ox40l antibodies and methods using same
WO2003072803A3 (en) Nanostructures containing antibody assembly units
WO2006099604A3 (en) Methods and compositions for assay readouts on multiple analytical platforms
WO2006042112A3 (en) Aptamer regulated nucleic acids and uses thereof
WO2007008276A3 (en) Turnover probes and use thereof for nucleic acid detection
WO2004029207A3 (en) Optimized fc variants and methods for their generation
WO2006105062A3 (en) Altered antibody fc regions and uses thereof
WO2005017646A3 (en) System, software and methods for biomarker identification
WO2005107476A3 (en) Berry oils and products
WO2005087951A3 (en) Reagents, methods and kits for use in deactivating nucleic acids
WO2006014638A3 (en) ANTIBODIES TO CROSS-LINKED AMYLOID β OLIGOMERS
WO2006086669A3 (en) Aptamer regulated nucleic acids and uses thereof
WO2005114452A3 (en) Service oriented architecture
WO2006135904A3 (en) Method for producing improved results for applications which directly or indirectly utilize gene expression assay results
WO2005041896A3 (en) Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke
WO2003093472A3 (de) Cgrp bindende nukleinsäuren
WO2004087735A3 (en) Proteolytic and covalent antibodies
WO2002053104A3 (en) Use of catecholamine reuptake inhibitors to enhance memory
WO2003078574A3 (en) Novel metabolic targets and markers
WO2005076939A3 (en) Assay and method for diagnosing and treating alzheimer’s disease
WO2003048309A3 (en) Thermus thermophilus nucleic acid polymerases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase